Evofem Biosciences Inc (EVFM)
0.011
0.00 (0.00%)
USD |
OTCM |
Jun 21, 15:57
Evofem Biosciences Profit Margin (Quarterly): -133.5% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -133.5% |
| December 31, 2023 | -43.69% |
| September 30, 2023 | |
| June 30, 2023 | -348.2% |
| March 31, 2023 | -40.52% |
| December 31, 2022 | -4.61K% |
| September 30, 2022 | |
| June 30, 2022 | -2.09K% |
| Date | Value |
|---|---|
| March 31, 2022 | -750.1% |
| December 31, 2021 | -1.44K% |
| September 30, 2021 | -4.33K% |
| June 30, 2021 | -1.80K% |
| March 31, 2021 | -4.18K% |
| December 31, 2020 | -24.17K% |
| September 30, 2020 | -10.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-24.17K%
Minimum
Dec 2020
-40.52%
Maximum
Mar 2023
-4.21K%
Average
-1.80K%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 349.9% |
| Gross Profit Margin (Quarterly) | 81.02% |
| Operating Margin (Quarterly) | -78.93% |
| Return on Net Operating Assets | 401.0% |